RCM
LH icon

Riverhead Capital Management’s Labcorp LH Stock Holding History

Riverhead Capital Management’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$5.81M Buy
40,281
+11,756
+41% +$1.72M 0.21% 116
2019
Q2 		$4.24M Buy
28,525
+9,894
+53% +$1.38M 0.16% 172
2019
Q1 		$2.45M Buy
18,631
+6,053
+48% +$746K 0.1% 272
2018
Q4 		$1.36M Sell
12,578
-176
-1% -$23.6K 0.06% 365
2018
Q3 		$1.9M Buy
12,754
+116
+0.9% +$17.6K 0.07% 326
2018
Q2 		$1.95M Buy
12,638
+3,019
+31% +$456K 0.08% 312
2018
Q1 		$1.34M Sell
9,619
-213
-2% -$31.3K 0.06% 352
2017
Q4 		$1.35M Buy
9,832
+338
+4% +$44.7K 0.06% 354
2017
Q3 		$1.23M Sell
9,494
-2,444
-20% -$326K 0.06% 351
2017
Q2 		$1.58M Sell
11,938
-253
-2% -$31K 0.08% 299
2017
Q1 		$1.5M Buy
12,191
+369
+3% +$43.7K 0.08% 291
2016
Q4 		$1.3M Sell
11,822
-116
-1% -$12.9K 0.08% 300
2016
Q3 		$1.41M Buy
11,938
+10,209
+590% +$1.2M 0.09% 276
2016
Q2 		$18K Sell
1,729
-75,272
-98% -$8.1M ﹤0.01% 1409
2016
Q1 		$7.75M Sell
77,001
-23,869
-24% -$2.29M 0.11% 238
2015
Q4 		$10.7M Buy
100,870
+32,197
+47% +$3.32M 0.16% 170
2015
Q3 		$6.4M Buy
68,673
+11,984
+21% +$1.24M 0.1% 274
2015
Q2 		$5.9M Buy
56,689
+9,155
+19% +$953K 0.09% 289
2015
Q1 		$5.15M Buy
47,534
+12,978
+38% +$1.33M 0.08% 300
2014
Q4 		$3.2M Buy
34,556
+2,416
+8% +$213K 0.05% 387
2014
Q3 		$2.81M Buy
32,140
+2,510
+8% +$227K 0.05% 386
2014
Q2 		$2.61M Buy
29,630
+2,708
+10% +$235K 0.05% 385
2014
Q1 		$2.27M Sell
26,922
-37,517
-58% -$2.99M 0.05% 377
2013
Q4 		$5.06M Buy
64,439
+5,075
+9% +$433K 0.13% 217
2013
Q3 		$5.06M Buy
59,364
+32,592
+122% +$2.74M 0.16% 163
2013
Q2 		$2.3M Buy
+26,772
New +$2.22M 0.08% 249

Other funds holding LH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MCM
Melvin Capital Management New York $9.86B AUM 16.31% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Riverhead Capital Management's LH Position: Q3 2019 in Review

Riverhead Capital Management increased its Labcorp (LH) stake by 41% in Q3 2019, buying an estimated $1.72M and bringing the position to 40,281 shares worth $5.81M. The position accounts for 0.21% of the portfolio, ranked #116.

Riverhead Capital Management first reported a position in LH in Q2 2013 and has held it in 26 quarters since. The position peaked at $10.7M in Q4 2015. 738 funds tracked by Wall St. Rank hold LH as of Q3 2019.

  • Riverhead Capital Management held 40,281 shares of Labcorp worth $5.81M as of Q3 2019.
  • Riverhead Capital Management bought 11,756 Labcorp shares in Q3 2019, an estimated $1.72M.
  • Labcorp made up 0.21% of Riverhead Capital Management's portfolio in Q3 2019, its #116 holding.
  • Riverhead Capital Management first reported a position in Labcorp in Q2 2013 and has held it in 26 quarters since.
  • Riverhead Capital Management's Labcorp position peaked at $10.7M in Q4 2015.
  • 738 funds tracked by Wall St. Rank held Labcorp as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.